News Articles Tagged: Patient Survival

Imatinib Mesylate in Clinical Practice: From Development to Patient Survival

An exploration of the clinical journey of Imatinib Mesylate, from its groundbreaking development to its profound impact on patient survival rates in CML and GIST. NINGBO INNO PHARMCHEM CO.,LTD. highlights its significance.

Navigating Desmoid Tumor Treatment: Insights from the DeFi Trial and Nirogacestat's Role

A deep dive into the DeFi trial, highlighting progression-free survival, objective response rates, and patient-reported outcomes for nirogacestat. NINGBO INNO PHARMCHEM CO.,LTD. examines the implications for desmoid tumor management.